Write your message
Volume 7, Issue 1 (Winter 2022)                   J Obstet Gynecol Cancer Res 2022, 7(1): 52-58 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

razavi R, jahangard S. Coagulopathy State in Pregnant Women with COVID-19 involvement: 2 Case Reports. J Obstet Gynecol Cancer Res. 2022; 7 (1) :52-58
URL: http://jogcr.com/article-1-346-en.html
1- 1. Department of Obstetrics and Gynecology, School of Medicine, Solid Tumor Research Center, Research Institute on Cellular and Molecular Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran
2- 1. Department of Obstetrics and Gynecology, School of Medicine, Solid Tumor Research Center, Research Institute on Cellular and Molecular Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran , samira_sjgh@yahoo.com
Abstract:   (129 Views)
Pregnant women appear to be more severely affected by COVID-19. Coagulopathy is known as one of the most challenging effects of COVID-19, and the effects of acute airway diseases resulting from the coronavirus on pregnant mothers and their fetuses can be dangerous. Two women who where pregnant suffering from coagulopathy (one of them with disseminated intravascular coagulation (DIC) and the other one with hypercoagulation) and COVID-19 infection are reported in this study. During hospitalization due to severe vaginal bleeding and placental detachment, cesarean section was performed on the first caseand because of acute severe DIC, she received a massive transfusion. The second patient  epigastric pain and tachycardia. COVID-19 might have a variety of effects on pregnancy outcome, from vascular and placental involvement to respiratory involvement; there is an association between the coronavirus and hyper-coagulopathy state and coagulopathy like DIC.
Full-Text [PDF 493 kb]   (8 Downloads) |   |   Full-Text (HTML)  (5 Views)  
Systematic Review: Case Report | Subject: Maternal Fetal Medicine
Received: 2021/02/22 | Accepted: 2021/03/3 | Published: 2021/09/9

References
1. Zaigham M, Andersson O. Maternal, and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstetricia et Gynecologica Scandinavica. 2020;99(7):823-9. [DOI:10.1111/aogs.13867]
2. Gao Y-j, Ye L, Zhang J-s, Yin Y-x, Liu M, Yu H-b, et al. Clinical features and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis. 2020 [DOI:10.21203/rs.3.rs-27148/v1]
3. Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental Pathology in COVID-19. Am J Clin Pathol. 2020;154(1):23-32. [DOI:10.1093/ajcp/aqaa089]
4. Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29 [DOI:10.1016/j.eclinm.2020.100639]
5. Takeda J, Takeda S. Management of disseminated intravascular coagulation associated with placental abruption and measures to improve outcomes. Obstet Gynecol Sci. 2019;62(5):299-306. [DOI:10.5468/ogs.2019.62.5.299]
6. RCOG. COVID-19 virus infection and pregnancy. Occupational health advice for employers and pregnant women during the COVID-19 pandemic. Royal College of Obstetrics and Gynaecology, United Kingdom, 2020.
7. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020. 10.1016/S2468-1253(20)30057-1. [DOI:10.1016/S2468-1253(20)30057-1]
8. Vlachodimitropoulou Koumoutsea E, Vivanti AJ, Shehata N, Benachi A, Le Gouez A, Desconclois C, et al. COVID-19, and acute coagulopathy in pregnancy. J Thromb Haemost. 2020;18(7):1648-52. [DOI:10.1111/jth.14856]
9. Chen S, Huang B, Luo DJ, et al. Pregnant women with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2020;49:E005.
10. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020. 10.1016/S2468-1253(20)30057-1. [DOI:10.1016/S2468-1253(20)30057-1]
11. Ng WF, Wong SF, Lam A, et al. . The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology. 2006;38:210-218 [DOI:10.1080/00313020600696280]
12. Garcia AG, Fonseca EF, Marques RL, et al. Placental morphology in cytomegalovirus infection. Placenta. 1989;10:1-18 [DOI:10.1016/0143-4004(89)90002-7]
13. . Chen S, Huang B, Luo DJ, et al. Pregnant women with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2020;49:E005.
14. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62. [DOI:10.1016/S0140-6736(20)30566-3]
15. Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and derangement of the renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167-73. [DOI:10.1016/j.cca.2020.04.027]
16. Ruiter L, Ravelli AC, De Graaf IM, Mol BWJ, Pajkrt E. Incidence and recurrence rate of placental abruption: a longitudinal linked national cohort study in the Netherlands. American journal of obstetrics and gynecology. 2015;213(4):573. e1-. e8. [DOI:10.1016/j.ajog.2015.06.019]
17. Carr SR. High risk pregnancy: management options. JAMA; 1995;273:259-60. [DOI:10.1001/jama.1995.03520270095051]
18. Franco-Moreno A, Herrera-Morueco M, Mestre-Gómez B, Muñoz-Rivas N, Abad-Motos A, Salazar-Chiriboga D, et al. Incidence of Deep Venous Thrombosis in Patients With COVID-19 and Pulmonary Embolism. Journal of Ultrasound in Medicine. 2020;n/a(n/a) [DOI:10.1002/jum.15524]
19. Lawin-O'Brien A, Nelson-Piercy C. Thromboprophylaxis in Pregnancy. In: Hunt B, Pavord S, editors. The Obstetric Hematology Manual. 2 ed. Cambridge: Cambridge University Press; 2018. p. 139-49. [DOI:10.1017/9781316410837.015]
20. Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S, et al. Management of Thrombotic Complications in COVID-19: An Update. Drugs. 2020;80(15):1553-62. [DOI:10.1007/s40265-020-01377-x]
21. White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D, et al. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020;50(2):287-91 [DOI:10.1007/s11239-020-02145-0]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.